Clinical Trials Browser

Phase 3 × Coronary Disease × evolocumab × Clear all

NCT03872401 2025-11-10

VESALIUS-CV

Phase 3 Completed

12,301 enrolled

Coronary Disease, Multiple Endocrine Neoplasia Type 1